Stocks
State Street SPDR S&P Biotech ETFXBI
AMEXHealthcareBiotechnology$121.83-0.64%
An exchange-traded fund designed to track the performance of the S&P Biotechnology Select Industry Index, holding a broad basket of U.S.-listed biotechnology companies. The fund uses a modified equal-weight approach, giving smaller clinical-stage biotech firms greater representation than market-cap-...
Market Cap: $6.3B52W Range: $66.66 – $132.09
Congressional Interest in State Street SPDR S&P Biotech ETF (XBI)
13 members of Congress have disclosed 27 trades in State Street SPDR S&P Biotech ETF (XBI), a Healthcare company. The buy/sell breakdown shows 12 purchases versus 15 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
27
Unique Politicians
13
Buys
12
Sells
15
Who in Congress Is Trading XBI?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-10-18 | Rohit Khanna | sell | $50K – $100K |
| 2024-07-15 | Rohit Khanna | sell | $100K – $250K |